Aigen Investment Management’s Edwards Lifesciences EW Stock Holding History

Aigen Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Buy	16,910 +12,982	+330%	+$1.09M	0.42%	68
2026 Q1	$315K	Buy	+3,928	New	+$324K	0.08%	320
2025 Q4	–	Sell	-6,408	Closed	-$498K	–	709
2025 Q3	$498K	Sell	6,408 -8,624	-57%	-$674K	0.08%	400
2025 Q2	$1.18M	Sell	15,032 -9,058	-38%	-$676K	0.16%	203
2025 Q1	$1.75M	Buy	+24,090	New	+$1.72M	0.28%	100
2024 Q2	–	Sell	-4,532	Closed	-$433K	–	855
2024 Q1	$433K	Buy	+4,532	New	+$381K	0.09%	321
2023 Q1	–	Sell	-98,859	Closed	-$7.38M	–	680
2022 Q4	$7.38M	Buy	+98,859	New	+$7.62M	1.04%	16
2022 Q1	–	Sell	-10,042	Closed	-$1.27M	–	711
2021 Q4	$1.27M	Buy	+10,042	New	+$1.17M	0.08%	341
2021 Q2	–	Sell	-3,010	Closed	-$252K	–	554
2021 Q1	$252K	Buy	+3,010	New	+$254K	0.03%	469
2020 Q4	–	Sell	-3,420	Closed	-$273K	–	849
2020 Q3	$273K	Sell	3,420 -15,838	-82%	-$1.24M	0.03%	568
2020 Q2	$1.33M	Sell	19,258 -16,199	-46%	-$1.15M	0.17%	177
2020 Q1	$2.23M	Buy	35,457 +34,743	+4,866%	+$2.51M	0.3%	76
2019 Q4	$56K	Buy	+714	New	+$55.8K	0.01%	794

Other funds holding EW

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Aigen Investment Management's EW Position: Q2 2026 in Review

Aigen Investment Management increased its Edwards Lifesciences (EW) stake by 330% in Q2 2026, buying an estimated $1.09M and bringing the position to 16,910 shares worth $1.53M. The position accounts for 0.42% of the portfolio, ranked #68.

Aigen Investment Management first reported a position in EW in Q4 2019 and has held it in 13 quarters since. The position peaked at $7.38M in Q4 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

Aigen Investment Management held 16,910 shares of Edwards Lifesciences worth $1.53M as of Q2 2026.
Aigen Investment Management bought 12,982 Edwards Lifesciences shares in Q2 2026, an estimated $1.09M.
Edwards Lifesciences made up 0.42% of Aigen Investment Management's portfolio in Q2 2026, its #68 holding.
Aigen Investment Management first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 13 quarters since.
Aigen Investment Management's Edwards Lifesciences position peaked at $7.38M in Q4 2022.
1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.